Search This Blog

Monday, August 5, 2019

Acceleron Pharma EPS misses by $0.11, misses on revenue

Acceleron Pharma (NASDAQ:XLRN): Q2 GAAP EPS of -$0.34 misses by $0.11.
Revenue of $27.67M (+649.9% Y/Y) misses by $1.05M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)